Working Volume of 2.0ml
Round well with ‘U’ bottom to aid mixing, pelleting and washing
High uniformity from well to well
Raised well rims for reliable closing with heat sealing.
Easy and reliable stacking
Good centrifugation stability up to 6,000 × g for faster protocols and improved sample quality
Manufactured under DNase/ RNase free environment without slip agents, plasticizers or biocides – Materials which could have a negative effect on bioassays
Pure, virgin polypropylene guarantees good extractible performance, high resistance to chemicals, good mechanical stress and working with temperature extremes
Autoclavable (121 °C, 20 min)
Detail
Overview
Working Volume of 2.0ml
Round well with ‘U’ bottom to aid mixing, pelleting and washing
High uniformity from well to well
Raised well rims for reliable closing with heat sealing.
Easy and reliable stacking
Good centrifugation stability up to 6,000 × g for faster protocols and improved sample quality
Manufactured under DNase/ RNase free environment without slip agents, plasticizers or biocides – Materials which could have a negative effect on bioassays
Pure, virgin polypropylene guarantees good extractible performance, high resistance to chemicals, good mechanical stress and working with temperature extremes
Programmed Death-Ligand 1 (PD-L1), also known as CD274 or B7 Homolog 1 (B7-H1), is a transmembrane protein involved in suppressing the immune system and rendering tumor cells resistant to CD8 T cell-mediated lysis through binding of the Programmed Death-1 (PD-1) receptor. Overexpression of PD-L1 may allow cancer cells to evade the actions of the host immune system. In renal cell carcinoma, upregulation of PD-L1 has been linked to increased tumor aggressiveness and risk of death, and, in ovarian cancer, higher expression of this protein has lead to significantly poorer prognosis. PD-L1 has also been linked to systemic lupus erythematosus and cutaneous melanoma. When considered in adjunct with CD8 tumor-infiltrating lymphocyte density, expression levels of PD-L1 may be a useful predictor of multiple cancer types, including stage III non-small cell lung cancer, hormone receptor negative breast cancer, and sentinel lymph node melanoma.
1. Microprocessor control, digital display, touch panel, parameters in running can be edited and change to display other running parameter and RCF.
2. Brushless frequency motor with simpler construction, more reliable performance, longer life and quietly running.
3. Automatic lid lock, super speed, over temperature protection and imbalance protection. The centrifuge body is made of high quality steel, safe and reliable.
4. Adapters are available by experiment requirements.
5. 3 tiers protection steel cover, safe and reliable.
6. TUV CE EMC certificate.
TD5A Technical Parameter:
Max. Speed
5000rpm
Max. RCF
4730×g
Max. Capacity
4×300ml
Time Range
0~99min
RPM/RCF Convert
Yes
Noise (dB)
≤ 58
Temperature
Normal
Acc/Dec
10 Kinds
Speed Accuracy
±20r/min
Temperature Accuracy
/
Voltage(V/Hz)
AC 220V/110V 50HZ/60HZ
Size (W x D x Hmm)
620×450×355mm
Net Weight(Kg)
52KG
Certificates
CE,ISO & Calibration report are available
Matched Rotor for TD5A
Order NO.
Rotor Type
Max speed(r/min)
Volume (ml)
Max RCF(*g)
5A-1
Swing rotor (round cup)
4000
4×300ml
3180
5A-2
Swing rotor (square cup)
4000
4×300ml
3150
5A-3
Swing rotor
4000
4×24×7ml
3150
4000
4×24×5ml
2750
4000
4×18×10ml
3140
5A-4
Microplate rotor
4000
2×4×96 well
2910
5A-5
Microplate rotor
4000
2×4×48 well
2300
5A-6
Swing rotor
5000
4×1×50ml
4730
5000
4×1×100ml
4730
5A-7
Swing rotor
4000
4×2×50ml
3200
4000
4×2×100ml
3020
4000
4×4×15ml
3200
4000
4×6×15ml
3200
4000
4×8×15ml
3200
4000
4×12×5ml vacuum tube
2480
4000
4×12×7ml vacuum tube
2760
4000
4×12×10ml vacuum tube
2790
4000
4×8×10/7/5ml vacuum tube
2790
4000
4×6×10/7/5ml vacuum tube
2790
4000
4×4×10/7/5ml vacuum tube
2790
5A-8
Fixed Rotor
5000
6×15ml
2540
5A-9
Fixed Rotor
5000
12×15ml
3080
5A-10
Fixed Rotor
5000
24×15ml
3500
5A-11
Fixed Rotor
5000
30×15ml
3830
5A-12
Fixed Rotor
5000
4×50ml
2520
5A-13
Fixed Rotor
5000
6×50ml
2850
5A-14
Fixed Rotor
5000
12×50ml
3860
5A-15
Fixed Rotor
4000
24×50ml
2970
5A-16
Fixed Rotor
5000
4×100ml
2630
5A-17
Fixed Rotor
5000
6×100ml
3130
5A-18
Fixed Rotor
4000
12×100ml
2970
Document
TD5A centrifuge Max Capacity 4x300ml swing out rotor, max speed 5000rpm, can hold 96 vacuum tubes
[RI1001] RNAok™ RNase Inhibitor, 20 U/μl, 2000 U x 5
Product Info
Document
Product Info
Description
The RNAok™ RNase Inhibitor is a recombinant mammalian RNase inhibitor which possesses very high affinity for eukaryotic pancreatic-type ribonuclease. The RNAok™ RNase Inhibitor forms a 1:1 complex with pancreatic RNase A by noncovalent binding, presenting a noncompetitive inhibitory activity on these pancreatic enzymes. RNAok™ RNase Inhibitor is active against RNase A, RNase B, RNase C but not RNAse H, RNase I, RNase T1, RNase T2, and S1 nuclease. RNAok™ RNase Inhibitor is compatible with RT-PCR enzymes such as AMV, M-MLV and ExcelRT™ Reverse Transcriptase or Taq DNA polymerase.
Application
cDNA Synthesis
in vitro translation
in vitro transcription
One-step RT-PCR
Separation and identification of specific ribonuclease activities
Storage Buffer
40 mM HEPES-KOH (pH 7.5), 100 mM KCl, 8 mM DTT, 0.1 mM EDTA, stabilizer and 50% (v/v) glycerol
Storage
-20°C for 24 months
Document
The RNAok™ RNase Inhibitor is a recombinant mammalian RNase inhibitor which possesses very high affinity for eukaryotic pancreatic-type ribonuclease. The RNAok™ RNase Inhibitor forms a 1:1 complex with pancreatic RNase A by noncovalent binding, presenting a noncompetitive inhibitory activity on these pancreatic enzymes. RNAok™ RNase Inhibitor is active against RNase A, RNase B, RNase C but not RNAse H, RNase I, RNase T1, RNase T2, and S1 nuclease. RNAok™ RNase Inhibitor is compatible with RT-PCR enzymes such as AMV, M-MLV and ExcelRT™ Reverse Transcriptase or Taq DNA polymerase.